Painchek Ltd (AU:PCK) — Market Cap & Net Worth
Market Cap & Net Worth: Painchek Ltd (PCK)
Painchek Ltd (AU:PCK) has a market capitalization of $21.44 Million (AU$30.31 Million) as of May 2, 2026. Listed on the AU stock exchange, this Australia-based company holds position #24819 globally and #1071 in its home market, demonstrating a -3.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Painchek Ltd's stock price AU$0.15 by its total outstanding shares 209007312 (209.01 Million). Analyse PCK cash flow metrics to see how efficiently the company converts income to cash.
Painchek Ltd Market Cap History: 2015 to 2026
Painchek Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.87 Million to $21.44 Million (15.62% CAGR).
Painchek Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Painchek Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
12.75x
Painchek Ltd's market cap is 12.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.42 Million | $3.89K | -$5.05 Million | 1136.12x | N/A |
| 2017 | $9.14 Million | $31.12K | -$8.47 Million | 293.72x | N/A |
| 2018 | $5.75 Million | $50.65K | -$4.81 Million | 113.59x | N/A |
| 2019 | $28.01 Million | $215.46K | -$3.26 Million | 130.00x | N/A |
| 2020 | $11.36 Million | $248.19K | -$12.39 Million | 45.76x | N/A |
| 2021 | $7.81 Million | $214.80K | -$6.06 Million | 36.35x | N/A |
| 2022 | $5.03 Million | $978.57K | -$5.72 Million | 5.14x | N/A |
| 2023 | $5.47 Million | $1.95 Million | -$7.57 Million | 2.81x | N/A |
| 2024 | $4.29 Million | $2.67 Million | -$8.31 Million | 1.61x | N/A |
| 2025 | $42.89 Million | $3.36 Million | -$7.67 Million | 12.75x | N/A |
Competitor Companies of PCK by Market Capitalization
Companies near Painchek Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Painchek Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
Painchek Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Painchek Ltd's market cap moved from $3.87 Million to $ 21.44 Million, with a yearly change of 15.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$21.44 Million | -50.00% |
| 2025 | AU$42.89 Million | +900.00% |
| 2024 | AU$4.29 Million | -21.62% |
| 2023 | AU$5.47 Million | +8.82% |
| 2022 | AU$5.03 Million | -35.61% |
| 2021 | AU$7.81 Million | -31.25% |
| 2020 | AU$11.36 Million | -59.45% |
| 2019 | AU$28.01 Million | +386.89% |
| 2018 | AU$5.75 Million | -37.06% |
| 2017 | AU$9.14 Million | +106.69% |
| 2016 | AU$4.42 Million | +14.12% |
| 2015 | AU$3.87 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Painchek Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.44 Million USD |
| MoneyControl | $21.44 Million USD |
| MarketWatch | $21.44 Million USD |
| marketcap.company | $21.44 Million USD |
| Reuters | $21.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more